Controversy Erupts Over Startup Offering IQ Screening for Embryos

Heliospect Genomics, a new startup, offers controversial embryo screening for high intelligence, sparking ethical debates in reproductive technology. With a $50,000 price tag, the service raises concerns about eugenics and access disparities. Experts emphasize the need for ethical regulations as the commercialization of genetic enhancements challenges societal values.